RG7834
Catalog No. A21816
RG7834 (RO 7020322) is a highly selective and orally bioavailable HBV inhibitor, potently inhibits HBV antigens (both HBsAg and HBeAg) and HBV DNA, with IC50s of 2.8, 2.6, and 3.2 nM, respectively, in dHepaRG Cells.
Catalog Num | A21816 |
---|---|
M. Wt | 401.45 |
Formula | C22H27NO6 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 2072057-17-9 |
Synonyms | RO 7020322, RO-7020322, RO7020322; RG 7834, RG-7834 |
SMILES | O=C(O)C1=CN2[C@@H](CC3=CC(OCCCOC)=C(C=C3C2=CC1=O)OC)C(C)C |
RG7834 (RO 7020322) is a highly selective and orally bioavailable HBV inhibitor, potently inhibits HBV antigens (both HBsAg and HBeAg) and HBV DNA, with IC50s of 2.8, 2.6, and 3.2 nM, respectively, in dHepaRG Cells.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.91 mL | 124.55 mL | 249.1 mL |
0.5 mM | 4.98 mL | 24.91 mL | 49.82 mL |
1 mM | 2.49 mL | 12.45 mL | 24.91 mL |
5 mM | 0.5 mL | 2.49 mL | 4.98 mL |
*The above data is based on the productmolecular weight 401.45. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.